PCI Biotech Holding ASA banner

PCI Biotech Holding ASA
OSE:PCIB

Watchlist Manager
PCI Biotech Holding ASA Logo
PCI Biotech Holding ASA
OSE:PCIB
Watchlist
Price: 0.07 NOK -39.13% Market Closed
Market Cap: kr4.3m

Wall St Price Targets

PCIB Price Targets Summary
PCI Biotech Holding ASA

There are no price targets for PCIB.
Lowest Forecast
Price Target
Not Available
Average Forecast
Price Target
Not Available
Highest Forecast
Price Target
Not Available
PCI Biotech Holding ASA Competitors:
Price Targets
IDXX
IDEXX Laboratories Inc
30% Upside
DXPE
DXP Enterprises Inc
-9% Downside
NN
NextNav Inc
128% Upside
FAF
First American Financial Corp
5% Upside
CRPR
James Cropper PLC
10% Upside

Revenue
Forecast

-1% / Year
Past Growth
9% / Year
Estimated Growth
Estimates Accuracy
-17%
Average Miss
-1% / Year
Past Growth
9% / Year
Estimated Growth
Estimates Accuracy
-17%
Average Miss

Over the last 13 years, the compound annual growth rate for Revenue has been -1%. The projected CAGR for the next 3 years is 9%.

Gross Profit
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
Gross Profit Forecast
is not available for PCI Biotech Holding ASA

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-5%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-5%
Average Miss

Pre-Tax Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-7%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-7%
Average Miss

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-7%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-7%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is PCIB's stock price target?
Not Available

PCIB does not have any price targets made by Wall Street professionals.

What is the Revenue forecast for PCI Biotech Holding ASA?
Projected CAGR
9%

Over the last 13 years, the compound annual growth rate for Revenue has been -1%. The projected CAGR for the next 3 years is 9%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett